As demonstrated by these studies and the available evidence, sST2 levels vary across different cancer types; however, the majority of recent findings indicate an overall trend toward increased expression of this molecule.
← all excerpts
Diagnostic Value of Serum sST2 and MicroRNA-29a in Ovarian Cancer: A Dual-Biomarker Pilot Study.
1
—
—